Profile data is unavailable for this security.
About the company
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.
- Revenue in USD (TTM)9.61m
- Net income in USD-14.75m
- Incorporated1986
- Employees25.00
- LocationThermogenesis Holdings Inc2711 Citrus RdRANCHO CORDOVA 95742-6228United StatesUSA
- Phone+1 (916) 858-5100
- Fax+1 (916) 858-5199
- Websitehttps://thermogenesis.com